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Objective: To better understand the association between skeletal muscle and exercise intolerance in peripheral arterial
disease (PAD), we assessed treadmill-walking performance and gastrocnemius muscle phenotype in healthy control
subjects and in patients with PAD. We hypothesized that gastrocnemius muscle characteristics would be altered in PAD
compared with control subjects and that exercise tolerance in patients PAD would be related to muscle phenotype.
Methods: Sixteen patients with PAD and intermittent claudication and 13 healthy controls of the same age participated.
Each subject completed a graded treadmill-walking test and underwent a resting muscle biopsy. Muscle biopsy samples
were obtained from the medial gastrocnemius muscle of the most ischemic limb in PAD and a limb chosen at random in
controls. Samples were analyzed for fiber type and cross-sectional area, capillary-to-fiber ratio, the number of capillaries
in contact with each fiber type, and the optical density of glycogen within each fiber by using histochemical procedures.
Total muscle glycogen content was determined biochemically.
Results: Exercise capacity measured on the incremental walking test in the PAD group was only 30% to 40% of that
observed in controls. The PAD group had a lower proportion of type Imuscle fibers (P< .05), fewer capillaries per muscle
fiber (P < .05), and tended to have smaller fiber areas (P  .08). The relative area of type I fibers, the capillary-to-fiber
ratio, capillary contacts with type I and IIa fibers, and the optical density of glycogen in type I fibers were all positively
correlated with exercise tolerance in the PAD group(P < .05) but not controls.
Conclusions: These data suggest that muscle phenotype is altered in PAD and that such alterations are associated with the
exercise intolerance in these patients. In light of these findings, therapies such as resistance training or electrical
stimulation that target skeletal muscle in PAD may prove beneficial, and further investigation of such therapies is
warranted. (J Vasc Surg 2005;41:802-7.)It is well known that peripheral arterial disease (PAD),
resulting in intermittent claudication, is associated with a
reduced exercise tolerance. Intolerance to common modes
of exercise like walking can reduce levels of daily physical
activity, lead to poor health, and impair quality of life.1 The
mechanisms underlying the functional impairment in these
patients are not fully understood, however.2
PAD is primarily a vascular disease, with the major
limitation being a restriction of arterial blood flow to the
lower limbs. Some evidence indicates that physiologic
changes within the skeletal muscle may also contribute to
the functional impairment,3 although the nature of these
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802alterations is not clear. Some investigators have found
gastrocnemius muscle fiber areas to be smaller in PAD,4,5
whereas others have found no difference between PAD
patients and healthy control subjects.1,6 Similarly, data in
relation to capillary supply and fiber type distribution are
conflicting, with no clear picture of whether these charac-
teristics are altered in PAD.1,4-10 Differences in muscle
carbohydrate metabolism amongst claudicants have also
been observed.11 The impact of PAD on muscle phenotype
is clearly an important area of research that requires clarifi-
cation. Furthermore, there is a need to establish what role
these physiologic alterations might have on exercise capac-
ity by exploring the relationship betweenmuscle phenotype
and exercise capacity needs to be established.
We aimed to further describe the gastrocnemius muscle
characteristics of PAD patients and a group of well-matched
healthy control subjects. In particular, we examined the mus-
cle fiber type distribution, cross-sectional area, capillary sup-
ply, and glycogen content and hypothesized that thesemuscle
characteristics would be significantly altered in PAD patients
compared with control subjects. A novel aspect of this study
was the investigation of the relationship between muscle phe-
notype and exercise capacity, and we hypothesized that the
various muscle fiber characteristics would be significantly cor-
related with walking capacity in PAD.
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Recruitment and screening. Subjects gave informed
consent to the experimental procedures, which were ap-
proved by the local ethics committee. Sixteen individuals
with PAD, defined as a resting ankle-to-brachial systolic
blood pressure index (ABI) .9 and a history of stable
intermittent claudication1 year, were included. Thirteen
healthy control subjects with no history of chronic disease
also participated. The ratio of men to women in each group
was the same (z  0.71, P  .48) (Table I). Subjects with
uncontrolled hypertension (180 mm Hg systolic), un-
controlled angina, or diabetes were excluded. All subjects
from both groups were sedentary in that they did not
engage in any regular physical activity and had completed
no more than one bout of continuous exercise (10 min-
utes) in any given 7-day period in the previous 12
months.12 For each leg in all subjects, the ABI was calcu-
lated using the highest systolic ankle pressure and the
highest brachial artery pressure. The “worse” leg of the
PAD patients was defined as that with the lowest post-
exercise ABI. Subject characteristics are presented in
Table I.
Graded treadmill test. After being familiarized with
testing procedures, subjects performed a graded treadmill
test on a motorized treadmill (Payne, Australia) at 3.2
km/h. The treadmill grade was set at 0% for the first 5
minutes and then increased by 3.5% every 3 minutes until
subjects reached their maximum. Maximal exercise time
was recorded and peak (vertical) power on the treadmill was
calculated using the equation: Peak power (W)  (grade/
100) · body mass · 9.81 · 0.89, where peak power is the
highest power generated in translating the center of mass in
the vertical direction and is measured in watts (W), grade is
treadmill elevation measured as percent incline, body mass is
measured in kg, 9.81 m · s2 · s1 is the acceleration due to
gravity, and 0.89 is the walking speed measured in m/s.
Heart rate (HR) was recorded with a Vantage portable
monitor (Polar Electro-Oy, Finland) and averaged over
15-second intervals. Pulmonary gas exchange measure-
ments of minute ventilation (VE), oxygen uptake (VO2),
and respiratory exchange ratio were made every 15 seconds
using the Q-Plex automated gas analysis system (Quinton,
Seattle). ABI was measured before and after the graded
treadmill test as per the method described under Recruit-
ment and screening.
Muscle characteristics. The calf muscle mass of each
subject was estimated using anthropometrical measure-
ments.13 Seventy-two hours after the graded treadmill test,
a resting muscle biopsy was performed using a 6-mm bore
percutaneous biopsy needle. After 30 minutes of rest, the
muscle biopsy was taken from a consistent location of the
medial gastrocnemius of the worse leg in PAD patients and
a randomly selected leg in the controls. The sample was
immediately divided, and one piece was frozen in liquid
nitrogen and stored at 80°C for the biochemical deter-
mination of muscle glycogen.14 The other piece was pre-
pared for histochemical analysis by orienting the tissue in alongitudinal fashion before immersing it in Tissue-Tek
embedding medium (Sakura Finetek, USA) and freezing it
in precooled isopentane.
For histochemical analyses, five serial cross sections
of the tissue were cut with a cryostat at 20°C and
mounted on cover slips, each in triplicate (15 sections in
total). Three of the sections (10 m thickness) were
stained for myosin adenosine triphosphatase to identify
type I (slow oxidative), IIa (fast oxidative), and IIb (fast
glycolytic) fibers.15
The cross-sectional area of each fiber was measured
with MCID image analysis software (Image Research Inc,
St. Catherines, Ontario, Canada). The two remaining sec-
tions (16 m) underwent periodic acid-Schiff (PAS) and
PAS-amylase staining to identify glycogen and capillaries,
respectively.16 Digital microphotographs of the glycogen
PAS stains were converted to 8-bit images (255 gray scale),
and integrated optical density measures (expressed as gray
level; 0  black and 255  white) were made within each
fiber. The optical density of glycogen in each fiber, relative
to the background optical density, was then calculated
using the equation: 100  log10 (background density/
fiber density).17
The total capillary-to-fiber ratio was calculated by di-
viding the number of capillaries by the number of fibers
counted. The number of capillaries in contact with each
individual fiber (i.e., capillary contacts) was also counted.
One control and two PAD subjects chose not to have a
muscle biopsy. In addition, low tissue yields from some of
the biopsies meant that a full complement of data was not
available for all the histochemical analyses (PAD, n  9 to
14; control, n  10 to 12).
Statistics. Muscle characteristics were compared using
a two-way (group-by-fiber type) analysis of variance and
differences were identified using Tukey’s test. All other
variables were compared between the groups using un-
paired t tests. The Pearson product moment correlation
coefficient was used to describe relationships between vari-
ables. Statistical significance was set at P  .05. Data are
Table I. Subject characteristics
Controls PAD
No. of subjects 13 16
Men 8 13
Height (cm) 170 (2) 168 (1)
Weight (kg) 75 (4) 73 (3)
Age (years) 62 (2) 63 (2)
Brachial systolic pressure
(mm Hg) 123 (3) 140 (5)*
Resting ABI worse leg — 0.58 (0.03)*
Resting ABI better leg — 0.75 (0.03)*
Resting ABI dominant 1.28 (0.02) —
Resting ABI nondominant 1.29 (0.02) —
PAD, Peripheral arterial disease; ABI, ankle-to-brachial index.
*Significantly different from controls (P  .05).expressed as mean  SEM.
JOURNAL OF VASCULAR SURGERY
May 2005804 Askew et alRESULTS
Maximal walking time and peak power attained on the
graded treadmill test were both lower in PAD patients than
in controls (Table II). Peak VO2, post exercise ABI, and
other physiologic responses on the treadmill test were also
significantly lower in the PAD group than in controls
(Table II).
There was no difference in estimated calf muscle mass
between the better (1538 62 g) andworse (1516 68 g)
PAD legs; both of these measures were less than that
observed in controls (1760  71 g; P  .05). Gastrocne-
mius muscle fiber data (Table III) are based on an average
fiber count of 176 17 and 195 18 in controls and PAD,
respectively. PAD muscle had a higher proportion of type
IIa, and a lower proportion of type I fibers than controls.
PAD muscle fibers tended to have smaller, by about 9%,
cross-sectional areas than controls (P  .08). This finding
was not affected by removing women from the analysis.
The relative area of muscle occupied by type I fibers was
significantly lower in PAD (49%  4% vs 64%  5%; P 
.05) and, for type IIa fibers, relatively higher in PAD (29%
 3% vs 16%  3%; P  .05). The relative area of type IIb
fibers did not differ between the groups (PAD, 22%  4%;
control, 19%  4%).
Gastrocnemius capillary-to-fiber ratio tended to be
lower in PAD subjects than in control (P .08), and PAD
subjects had fewer capillary contacts per fiber (Table III).
The magnitude of this difference, which was 15%, was not
altered when women were removed from the comparison.
When capillary-to-fiber ratio was expressed relative to aver-
age fiber area, the groups did not differ significantly (PAD,
353  19; CON, 404  29; P  .15). Muscle glycogen
content did not differ between PAD subjects and controls.
There was a significant fiber type effect where the relative
optical density of glycogen was lower in type I fibers than
type II fibers in PAD and controls (Table III).
Peak treadmill power in the PAD group was signifi-
cantly correlated with the capillary contacts of type I (Fig 1)
Table II. Peak performance and physiological data from
the graded treadmill-walking test in controls and PAD
subjects
Controls PAD
Maximal walking time (s) 1505 (62) 495 (57)*
Peak power (W) 179 (12) 73 (5)*
Peak VO2 (ml · kg
1 · min1) 37.4 (2.0) 16.7 (1.1)*
Peak VE (L/min) 109 (9) 49 (4)*
Peak RER 1.19 (0.03) 1.05 (0.02)*
Peak HR 169 (4) 120 (6)*
Postexercise ABI† 1.08 (0.02) 0.23 (0.02)*
PAD, Peripheral arterial disease; RER, respiratory exchange ratio;HR, heart
rate; ABI, ankle-brachial index.
*Significantly different from controls (P  .05).
†Postexercise ABI is from randomly selected limb in control subjects and the
worse limb in PAD patients (ie, the same limb that underwent muscle
biopsy).and IIa (r  .70) fibers but not type IIb. In addition,muscle glycogen content measured biochemically was sig-
nificantly correlated with treadmill peak power in PAD (r
.55), as was the density of glycogen in type I fibers (Fig 2).
The cross-sectional area of type I fibers was significantly
correlated with peak treadmill power in PAD subjects (r 
.72) and controls (r  .66). The strength of association
between maximal exercise time or peak VO2 and several
other muscle characteristics in the PAD group are listed in
Table IV. Neither resting nor postexercise ABI was corre-
lated with walking capacity or any of the muscle phenotype
variables in either group.
DISCUSSION
PAD is associated with a reduced exercise tolerance,
and this was reaffirmed in the present study where the
walking capacity of PAD subjects was only 30% to 40% of
that in control subjects. We found several alterations in the
gastrocnemius muscle of PAD patients that were signifi-
cantly correlated withmaximal walking capacity in the PAD
group but not in the controls. That the resting and postex-
ercise ABI was not correlated with walking capacity high-
lights the potential importance of skeletal muscle to exer-
cise intolerance in claudicants and the need to develop and
test novel therapies that target skeletal muscle in PAD.
The gastrocnemius muscle is particularly important to
study in PAD, because it is the most common site of
ischemic pain that limits exercise tolerance.18 Control val-
ues for the distribution of type I fibers (60%), capillary-to-
fiber ratio (2.1), and capillary contacts (4.7) fell within the
ranges previously reported for healthy men and women in
this age group.5-8,19,20
Calf muscle mass was reduced by 12% in the PAD
group compared with control subjects, confirming previous
observations in PAD patients.1,21 Such reductions in calf
muscle mass are thought to be due to muscle fiber atrophy
in PAD,4,5,21 which was also observed in the present study
(ie, 9% lower, P .08).
PAD muscle had fewer type I fibers (48%) than did
control. Consistent with the lower number of oxidative
type I fibers, estimates of capillary supply were also 20% to
25% lower in PAD subjects. Our data on these muscle
characteristics are in strong agreement with those reported
by Clyne et al,7 who studied the gastrocnemius medialis
muscle in 60 claudicants and 10 to 12 healthy controls.
Capillary rarefaction in skeletal muscle is a feature of
hypertension,22 and hypertensive patients also have a lower
proportion of type I fibers (48%) compared with normo-
tensive individuals (57%).23 Therefore, the altered muscle
phenotype in PAD patients may be directly attributable to
their hypertensive state (Table I), although no clear rela-
tionship between blood pressure and muscle characteristics
was evident in the present study.
Alternatively, common pathologic processes may ex-
plain the skeletal muscle changes in individuals with hyper-
tension and those with PAD. Physical activity is also known
to alter skeletal muscle phenotype. Although we attempted
to only enroll sedentary subjects, it is possible that PAD
subjects were habitually less active than control subjects
gen d
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characteristics. However, there is evidence that physical
activity levels of older PAD patients are not different from
that of healthy control subjects.5 Furthermore, in unilater-
ally diseased patients where activity levels are self-con-
trolled, it is confirmed that muscle mass is reduced in the
diseased limbs compared with asymptomatic limbs.1
Supervised exercise therapy has also been shown to
have no effect on muscle mass and on type I fiber distribu-
Table III. Skeletal muscle characteristics in controls and P
Fiber type (%) I
IIa
IIb
Fiber CSA (m2) I
IIa
IIb
Tot
Capillary-to-fiber ratio
Capillary contacts I
IIa
IIb
Tot
Capillary contacts *106/fiber CSA I
IIa
IIb
Tot
Relative optical density of glycogen (%) I
IIa
IIb
Tot
Glycogen content (mmol/kg d.w.)
PAD, Peripheral arterial disease; CSA, cross-sectional area.
*Significantly different from controls (P  .05).
†Significantly different from controls (P  .08).
‡Significant main effect between PAD and control for capillary contacts.
§Significant main effect between type I and type IIa and IIb fibers for glyco
Fig 1. The relationship between the capillary contacts of type I
fibers and peak power during treadmill walking in control subjects
(CON) and peripheral arterial disease (PAD) subjects.tion in claudicants.24,25 However, there is some evidence inPAD that resistance training increases muscle capillary sup-
ply and fiber cross-sectional area.24 Further research is
required to understand the effect of habitual physical activ-
ity and exercise on muscle phenotype in claudicants.
There are conflicting data in relation to the effect of
PAD on muscle phenotype. Although our data agree with
some studies, our findings do differ with others. Muscle
capillarization in PAD has been found to be lower, similar,
or higher than control values,5-9 and a wide range of type I
subjects
Controls PAD
62 (4) 49 (5)*
16 (3) 27 (3)*
22 (5) 24 (4)
5407 (292) 4842 (400)
5407 (292) 4842 (400)
4980 (528) 4423 (458)
5308 (350) 4649 (413)
2.1 (0.2) 1.6 (0.2)†
4.9 (0.3) 4.2 (0.3)
4.4 (0.3) 4.0 (0.4)
3.8 (0.2 3.4 (0.2)
4.7 (0.3) 4.0 (0.3)‡
976 (70) 942 (61)
943 (115) 872 (57)
1008 (152) 835 (69)
955 (68) 911 (52)
25.5 (1.2) 28.0 (1.2)§
31.3 (1.5) 32.5 (1.6)
31.0 (0.9) 31.2 (1.4)
27.4 (1.6) 29.7 (1.1)
351 (46) 361 (35)
ensity (P  .05).
Fig 2. The relationship between the relative optical density of
glycogen (PAS stain intensity) in type I fibers and peak power
during treadmill walking in control subjects (CON) and peripheral
arterial disease (PAD) subjects.AD
al
al
al
alfiber percentages have been observed across the different
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of hypertension or different physical activity levels, as de-
scribed above, might contribute to the variant muscle phe-
notype findings in the literature.
The wide range of findings in PAD might also reflect
the variation in its severity or duration, or both. As PAD
symptoms progress in severity from claudication to rest
pain, the composition of skeletal muscle shifts towards a
greater proportion of type I fibers.4,10,26 This might be
related to either the preferential loss of type II fibers in
more severe disease4,21 or fiber remodeling,4 or both, that
occurs in response to fiber denervation.1,27
Methodologic problems such as low sample sizes (N
5)6,10 may also account for some of the divergent findings.
In some studies, muscle samples have been obtained from
open biopsies during surgery under general anesthesia, and
findings may not be comparable to others, including this
study, where a percutaneous biopsy has been performed
under local anesthesia. An accurate histochemical analysis
of skeletal muscle requires 100 fibers,28 whereas several
PAD studies have used as few as 50 fibers.6 Finally, varia-
tions in the age and gender composition of the groups
might have contributed to the divergent findings among
PAD studies. In the present study, we tried to avoid as
many of these problems as possible, by taking large biopsy
samples, counting a large number of fibers in triplicate, and
comparing groups of the same age and similar gender
composition.
Considerable debate has emerged about the patho-
physiology of exercise intolerance in PAD, with a particular
focus on the roles of hemodynamic limitations versus
changes intrinsic to skeletal muscle.29 There is uncertainty
about their influences on exercise intolerance,29,30 and the
main aim of the present study was to further explore the
relationship between skeletal muscle phenotype and exer-
cise capacity. The potential importance of the differences in
skeletal muscle fiber type, fiber area, and capillarization
observed in the present study to exercise intolerance in
PAD are supported by the strong correlations between
these same variables and walking capacity (Table IV, Fig 1).
In addition, glycogen content in whole muscle and type I
muscle fibers (Fig 2) were positively correlated with walk-
ing performance. These histologic and biochemical data
add to other reports of significant correlations between the
metabolic characteristics of skeletal muscle and exercise
Table IV. Correlation coefficients for selected relationship
fiber characteristics in the peripheral arterial disease worst l
%Area
type I
%Area
type IIa
VO2 peak (ml · kg
1 · min1) .73* .09
Maximal exercise time (s) .57* .23
PAD, Peripheral arterial disease; C-F, capillary-to-fiber; CC, capillary conta
*Significant at P  .05.
†Significant at P  .10.tolerance in claudicants.25,31-34 That such correlationswere not observed in the controls is a consistent finding
among these studies and suggests these skeletal muscle
characteristics may be important to understanding exercise
intolerance in PAD.
Although correlations should not imply causality, sev-
eral of our findings suggest the following scenario of how
differences in skeletal muscle phenotype might contribute
to a reduced walking capacity. Calf pain usually limits
walking in claudicants,18 and we assume that calf muscle
fatigue occurs more rapidly35 and contributes to exercise
intolerance in claudicants compared with healthy controls.
Given that PAD muscle has more fatigable type II fibers
(than type I fibers), the recruitment of a greater number of
type II muscle fibers during walking is more likely and so a
greater rate of fatigue is more probable. The likelihood of
recruiting more type II muscle fibers is further increased by
the smaller calf muscle mass and, particularly, smaller mus-
cle fiber area; because for a given force output, moremuscle
fibers should be recruited in accordance with the size
principle (type I to type IIb). The lower capillarization of all
fiber types in PAD will render them more vulnerable to
hypoxia and, thus, fatigue.36,37 The positive correlations
between walking performance and type I glycogen content
in PAD suggests that lower muscle glycogen levels in those
fibers first recruited during walking (type I) would predis-
pose them to earlier failure and hasten the recruitment of
additional, more fatigable fibers.38
Although further research is required, these data sug-
gest that the differences in muscle characteristics we have
observedmight contribute to a greater recruitment of more
fatigable muscle fibers and thus lead to the reduced exercise
capacity in individuals with PAD. Alternatively, exercise
intolerance caused by claudication might lead to a reduc-
tion in habitual physical activity. This, in-turn, might con-
tribute to the altered muscle phenotype and could explain
the association between muscle characteristics and exercise
capacity in PAD. As already discussed, however, the effect
of variations in physical activity on muscle phenotype in
PAD needs to be confirmed.
Therapies targeting skeletal muscle, such as resistance
training or electrical stimulation, promote angiogenesis
and a fast-to-slow transition in muscle fibers in the presence
of improved fatigue resistance.24,39 Such therapies have
received little attention in PAD, and in light of our findings,
tween maximal exercise time or VO2 peak and muscle
%Area
type IIb
C-F
ratio
CC
type I
ROD-G
type I
.64* .65* .61* .50
.40 .72* .66* .61†
D-G, Relative optical density of glycogen.s be
imb
cts; ROfurther investigation of their use is warranted.
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smaller muscle fiber size, lower percentage of type I fibers,
and a lower capillary supply than healthy controls. These
variables, as well as the glycogen density of type I fibers,
were also positively correlated with walking capacity in
PAD only. Although there is a need to confirm if a cause-
and-effect relationship exists among these variables, these
data suggest that skeletal muscle phenotype is associated
with exercise intolerance in PAD and highlight the need to
develop and test therapies that target skeletal muscle.
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